Invenomic Capital Management’s Raymond James Financial RJF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49,016
Closed -$5.09M 162
2023
Q2
$5.09M Sell
49,016
-32,261
-40% -$3M 0.26% 83
2023
Q1
$7.58M Buy
+81,277
New +$8.61M 0.43% 72
2020
Q4
Sell
-2,816
Closed -$137K 170
2020
Q3
$137K Sell
2,816
-15,292
-84% -$740K 0.08% 133
2020
Q2
$831K Sell
18,108
-8,034
-31% -$362K 0.62% 58
2020
Q1
$1.1M Sell
26,142
-72,876
-74% -$4.11M 0.9% 39
2019
Q4
$5.91M Buy
+99,018
New +$5.72M 2.37% 4

Other funds holding RJF

Invenomic Capital Management's RJF Position: Q3 2023 in Review

Invenomic Capital Management sold out of Raymond James Financial (RJF) in Q3 2023, closing a stake of 49,016 shares — an estimated $5.09M sold.

Invenomic Capital Management first reported a position in RJF in Q4 2019 and held it in 6 quarters. The position peaked at $7.58M in Q1 2023. 654 funds tracked by Wall St. Rank hold RJF as of Q3 2023.

  • Invenomic Capital Management reported no remaining Raymond James Financial position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 49,016 Raymond James Financial shares in Q3 2023, an estimated $5.09M.
  • Invenomic Capital Management first reported a position in Raymond James Financial in Q4 2019 and held it in 6 quarters.
  • Invenomic Capital Management's Raymond James Financial position peaked at $7.58M in Q1 2023.
  • 654 funds tracked by Wall St. Rank held Raymond James Financial as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.